<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7464234\results\search\drug\results.xml">
  <result pre="a rapidly progressive and widespread alveolar damage [11]. Transmembrane Protease," exact="Serine" post="2 (TMPRSS2) by contrast, is a transmembrane serine protease"/>
  <result pre="the female gender. Genetic hormonal differences have been reported, and" exact="testosterone" post="seems to favor a more severe evolution of the"/>
  <result pre="consists of off-label or compassionate therapies, antiparasitic agents including chloroquine," exact="hydroxychloroquine" post="and nitazoxanide, antibiotics, antiretroviral agents, anti-inflammatory and anti-coagulant compounds"/>
  <result pre="RNA-Dependent RNA Polymerase Inhibitors (RdRp), there is Remdesivir (RDV), an" exact="adenosine" post="analog previously used as anti-Ebola virus drug recently approved"/>
  <result pre="of COVID-19 [59]. The TMPRSS2 cell entry of SARS-CoV-2 inhibitors" exact="camostat" post="mesylate, nafamostat, and bromhexine may treat COVID-19 [60]. Anti-inflammatory"/>
  <result pre="TMPRSS2 cell entry of SARS-CoV-2 inhibitors camostat mesylate, nafamostat, and" exact="bromhexine" post="may treat COVID-19 [60]. Anti-inflammatory molecules potentially efficacy against"/>
 </snippets>
</snippetsTree>
